help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on January 24, 2005, doi:10.1165/rcmb.2004-0250OC

Am. J. Respir. Cell Mol. Biol., Volume 32, Number 5, May 2005, 443-452

A more recent version of this article appeared on May 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-0250OCv1
32/5/443    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McMichael, J. W
Right arrow Articles by Sallenave, J.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McMichael, J. W
Right arrow Articles by Sallenave, J.-M.

Submitted on August 5, 2004
Revised on January 21, 2005

The antimicrobial antiprotease elafin binds to lipopolysaccharide and modulates macrophage responses

Jonathan W McMichael1, Ali Roghanian1, Lu Jiang1, Robert Ramage2, and Jean-Michel Sallenave1*

1 Rayne Laboratory, MRC Centre for Inflammation Research, Edinburgh University Medical School, Edinburgh, United Kingdom, 2 Department of Chemistry, Albachem-University of Edinburgh, Edinburgh, United Kingdom

* To whom correspondence should be addressed. E-mail: J.Sallenave{at}ed.ac.uk.

Lipopolysaccharide (LPS) of the outer membrane of Gram negative bacteria represent a primary target for innate immune responses. We demonstrate here that the antimicrobial/anti-neutrophil elastase full length elafin (FL-EL) is able to bind both smooth and rough forms of LPS. The N-terminus was shown to bind both forms of LPS more avidly. We demonstrate that the lipid A core-binding proteins polymyxin B (PB) and LPS-binding protein (LBP) compete with elafin for binding, and that LBP is able to displace pre-bound elafin from LPS. When PB, FL-EL, N-EL and C-EL were pre-incubated with LPS prior to addition to immobilised LBP, PB was the most potent inhibitor of LPS transfer to LBP. These data prompted us to examine the biological consequences of elafin binding to LPS, using TNF-alpha release by murine macrophages. In serum-containing conditions, N-EL had no effect whereas both C-EL and FL-EL inhibited TNF-alpha production. In serum-free conditions, however, all moieties had a stimulatory activity on TNF-alpha release, with C-EL being the most potent at the highest concentration. The differential biological activity of elafin in different conditions suggests a role for this molecule in either LPS detoxification or activation of innate immune responses, depending on the external cellular environment.




This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
A. Bellemare, N. Vernoux, D. Morisset, and Y. Bourbonnais
Human Pre-Elafin Inhibits a Pseudomonas aeruginosa-Secreted Peptidase and Prevents Its Proliferation in Complex Media
Antimicrob. Agents Chemother., February 1, 2008; 52(2): 483 - 490.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
A. Roghanian, S. E. Williams, T. A. Sheldrake, T. I. Brown, K. Oberheim, Z. Xing, S. E. M. Howie, and J.-M. Sallenave
The Antimicrobial/Elastase Inhibitor Elafin Regulates Lung Dendritic Cells and Adaptive Immunity
Am. J. Respir. Cell Mol. Biol., May 1, 2006; 34(5): 634 - 642.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2005 American Thoracic Society.